naphthoquinones and gamma-rubromycin

naphthoquinones has been researched along with gamma-rubromycin* in 2 studies

Other Studies

2 other study(ies) available for naphthoquinones and gamma-rubromycin

ArticleYear
An efficient formal synthesis of the human telomerase inhibitor (+/-)-gamma-rubromycin.
    Angewandte Chemie (International ed. in English), 2009, Volume: 48, Issue:43

    Topics: Anti-Bacterial Agents; Benzene Derivatives; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Isocoumarins; Molecular Conformation; Naphthoquinones; Quinones; Telomerase

2009
Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety.
    Biochemistry, 2000, May-23, Volume: 39, Issue:20

    We found that a group of rubromycins and their analogues, a class of quinone antibiotics that possesses benzofuran and benzodipyran rings to form a spiroketal system, strongly inhibited human telomerase as assessed with a modified telomeric repeat amplification protocol. beta- and gamma-Rubromycins and purpuromycin appeared to be the most potent telomerase inhibitors, with 50% inhibitory concentrations (IC(50)) of about 3 microM, and griseorhodins A and C also showed comparable potencies for the inhibition (IC(50) = 6-12 microM). In contrast, opening of the spiroketal system of beta-rubromycin, giving rise to alpha-rubromycin, substantially decreased its inhibitory potency toward telomerase (IC(50) > 200 microM), indicating the essential role of the spiroketal system in telomerase inhibition. A kinetic study of the inhibition by beta-rubromycin revealed a competitive interaction with respect to the telomerase substrate primer, with a K(i) of 0.74 microM, whereas a mixed type inhibition was observed with respect to the nucleotide substrate. beta-Rubromycin was also potent in inhibiting retroviral reverse transcriptases but had virtually no effect on other DNA/RNA-modifying enzymes including DNA and RNA polymerases, deoxyribonuclease, and topoisomerase. Although beta-rubromycin showed nonspecific cytotoxicities, reducing proliferation of cancer cells (IC(50) approximately 20 microM), we conclude that beta-rubromycin appears to be a lead structure for the development of more potent and selective inhibitors of human telomerase.

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Enzyme Activation; Growth Inhibitors; HeLa Cells; Humans; K562 Cells; Naphthoquinones; Polymerase Chain Reaction; Quinones; Reverse Transcriptase Inhibitors; Spiro Compounds; Structure-Activity Relationship; Substrate Specificity; Telomerase

2000